6 completed. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 6 |
| Phase 1 | 1 | Completed 1 |
Follow Verbal Behavior: new trials by email Literature Review of Verbal Behavior trials Research Report on Verbal Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Methylphenidate in Childhood Apraxia of Speech Methylphenidate Hydrochloride, Placebo - Childhood Apraxia of Speech | Phase 2 | Completed | Murdoch Childrens Research Institute | 18 | 2022-03-14 | 2026-10-13 |
| Visual Acoustic Biofeedback for RSE Via Telepractice Visual-Acoustic Biofeedback Treatment, No Treatment - Speech Sound Disorder | Phase 2 | Completed | Montclair State University | 40 | 2022-01-15 | 2026-02-17 |
| Building Sentences With Preschoolers Who Use AAC AAC Generative Language Intervention, Standard of Care / Business as Usual - Down Syndrome, Speech and Language Disorder | Phase 2 | Completed | University of Central Florida | 70 | 2018-05-11 | 2024-01-08 |
| SPI-1005 for the Treatment of Patients With Meniere's Disease 200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo - Meniere's Disease | Phase 2 | Completed | Sound Pharmaceuticals, Incorporated | 149 | 2017-09-28 | 2023-09-18 |
| Expiratory Muscle Training in Patients With Parkinson's Disease EMST - Active Treatment, sham EMST - Parkinson's Disease | Phase 1 / Phase 2 | Completed | University of Florida | 90 | 2004-01-01 | 2011-09-20 |
| Cleft Palate Surgery and Speech Development Furlow double z-plasty palatoplasty palate repair, Von Langenbeck palatoplasty palate repair - Cleft Lip, Cleft Palate | Phase 2 | Completed | University of Florida | 475 | 1996-02-01 | 2011-09-20 |
Speech (5) · Speech Intelligibility (2) · Speech Sound Disorder (2) · Apraxias (1) · Attention Deficit Disorder with Hyperactivity (1) · Cleft Lip (1) · Cleft Palate (1) · Cough (1) · Down Syndrome (1) · Hearing Loss (1) · Language Disorders (1) · Meniere Disease (1) · Parkinson Disease (1) · Respiratory Aspiration (1) · Tinnitus (1)
Behavior (6) · Communication (6) · Nervous System Diseases (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Mental Disorders (3) · Neurodevelopmental Disorders (3) · Neurologic Manifestations (3) · Communication Disorders (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Neurobehavioral Manifestations (2) · Abnormalities, Multiple (1) · Attention Deficit and Disruptive Behavior Disorders (1)
Commerce (1) · Methylphenidate (1) · Standard of Care (1) · ebselen (1)
University of Florida (2) · Montclair State University (1) · Murdoch Childrens Research Institute (1) · Sound Pharmaceuticals, Incorporated (1) · University of Central Florida (1)
United States (5) · Australia (1) · Brazil (1)
Angela Morgan, PhD (1) · Christine M Sapienza, Ph.D. (1) · Elaine R. Hitchcock, PhD (1) · Jonathan Kil, MD (1) · William N Williams, Ph.D (1)
R01DC016321 (1), R01DE010437 (1), R15DC019775 (1)